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I t d tin ro uc on ScreeningDesign
End Stage Renal Disease (ESRD) patients have an
 
R d i d l b t ll d t i l       an om ze p ace o con ro e  r a .
extremely high mortality Fifty percent of all deaths are  .       
di l l t d d d t dicar ovascu ar re a e  an  many ue o car ac InclusionPatients are allocated to 3 months
arrhythmias n=140
      
t t t ith l t f 2 3. rea men  w  supp emen s o   g n-  
PUFAs (Calamarine® 250/250TG) or
A hi h l f i h th i t d i
   
 g  preva ence o  var ous arr y m as are repor e  n placebo (olive oil) to examine the
dialysis patients Atrial fibrillation (AF) is the most common
      
ff t HRV d h th i .       Visit  1e ec s on  an  arr y m as 
arrhythmia and often asymptomatic but can be Randomizationrecorded by 48 hours ambulatory   ,    
t ti i ll d i th di l i t t t
     
symp oma c espec a y ur ng e a ys s rea men . ECG Holter monitoring
Furthermore the risk of stroke increases dramatically and
  .
 ,        
the mortality doubles  
Visit 2 Visit 2 
n 3 PUFA
 
Pl bStudy population
Autonomic cardiac dysfunction is often seen in patients
-  ace o 
Ch i di l i ti t t A lb        n= 70 n=70ron c a ys s pa en s a  a org 
with ESRD and this is expressed by attenuated Heart Rate University Hospital and Vendsyssel ,         
V i bilit (HRV) hi h i f th i ti i th
    
ar a y  w c  s a measure o  e var a on n e Hospital Hjørring Denmark
time interval between heartbeats Attenuated 24 hours HRV Visit 3 Visit 3
, , . 
S l i 140   .       amp e s ze n= .  
is associated with an increased risk of sudden cardiac         
d th i th l l ti d ESRD ti tea  n e genera  popu a on an  among  pa en s.
Visit 4 Visit 4
Marine n-3 polyunsaturated fatty acids (PUFAs) have been
   
        
h t i HRV d d th i k f is own o ncrease  an  re uce e r s  o  var ous 
arrhythmias This effect has only been sparsely.       
investigated in the high risk patients with ESRD who has a            
l i t k f 3 PUFAow n a e o  n-  s.
Study Procedures 
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(day 95)
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Start Holter End Holter Start Holter End Holter
Monitoring Monitoring Monitoring Monitoring
CG CGHypothesis E  E  
3 PUFA l t ti i 24 h HRV in-   supp emen a on ncreases  ours  n Blood samples Blood samples
chronic dialysis patients  .
n-3 PUFA supplementation reduces the level of Blood pressure Blood pressure       
t i l t h di (SVT ) t t i lsupraven r cu ar ac ycar a s , prema ure a r a
complexes (PACs) and premature ventricular complexes Interview Interview      
(PVCs) in chronic dialysis patients Randomization    .
Begin End
Investigational Investigational 
Product Product
Aims
Th f thi t d i t i ti t th ff t f 3e purpose o  s s u y s o nves ga e e e ec s o  n-  
PUFA supplementation on HRV and arrhythmias in patients        
with ESRD. 
Primary endpoint 
• 24 hours HRV – SDNN (standard deviation of NN intervals)
Perspective
        
If we are able to demonstrate a significant effect of n 3 PUFAs oneSecondary endpoints            -     
might achieve a reduction in the risk of arrhythmias and by that• Other HRV indices              
ibl d bidi d li i hi hi h i k l i b
 
AF d SVT poss y re uce mor ty an  morta ty n t s g  r s  popu at on y •  an  s
a cheap and well tolerated nutritional supplement• Number of PACs        . 
• Number of PVCs and Lown classification    
